(7542068), R. E., (3563306), R. V., (6002243), M. M., (18619234), S. I. B., (18619237), A. S., (13730570), Y. A. A., . . . (7397276), N. M. A. (2019). Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Chicago Style (17th ed.) Citation(7542068), Ramesh Elango, Radhakrishnan Vishnubalaji (3563306), Muthurangan Manikandan (6002243), Sarah Ibrahim Binhamdan (18619234), Abdul-Aziz Siyal (18619237), Yasser A. Alshawakir (13730570), Musaad Alfayez (3571736), Abdullah Aldahmash (3563300), and Nehad M. Alajez (7397276). Concurrent Targeting of BMI1 and CDK4/6 Abrogates Tumor Growth in Vitro and in Vivo. 2019.
MLA (9th ed.) Citation(7542068), Ramesh Elango, et al. Concurrent Targeting of BMI1 and CDK4/6 Abrogates Tumor Growth in Vitro and in Vivo. 2019.